First reported 11 hours ago -
Updated 11 hours ago -
1 reports
3i Group plc, a UK-based private equity firm, has agreed to sell Xellia Pharmaceuticals A/S, a Norway-based pharmaceutical company focused on the development, manufacturing and global commercialization of anti-infective treatments, to Novo A/S, a Denmark-based ...
[Published Individual.com - 11 hours ago]